Halcyon Organics is the first Medical Marijuana Company in The South. Atlanta, Georgia

Halcyon Organics bases our claims on the medical benefits of cannabis on reputable clinical research and studies.  This list represents only a small sample of 1000’s of positive clinical studies.  We will update this resource as our doctors find more data. 

The following studies demonstrate cannabis’ important medicinal value.  The old ‘marijuana drug war’ propaganda warned us that “there are over 100 chemicals in marijuana.”  This is true.  What they didn’t mention was that those hundreds of chemicals hold cures and treatments to some of mankind’s most insidious diseases.

Each link directs to the study described by the title. We have categorized the studies based upon what disease they treat.  Some studies prove medical efficacy for multiple conditions. This is some hard-core nerd stuff so open a browser tab and get a dictionary website ready.

The following studies prove that cannabis is a neuroprotectant and AChE inhibitor.  This is what makes medical marijuana superior treatment for neurodegenerative conditions like Alzheimer’s Disease and dementia.  These studies also prove efficacy in treating Chronic Traumatic Encephalopathy (CTE) caused from head injuries.  CTE is the condition that is causing NFL players to commit suicide.

Alzheimer’s Disease, Dementia, CTE:

The influence of cannabinoids on generic traits of neurodegeneration

Cannabinoids are Neuroprotective in human tissue samples_JNeurosci

Regulatory role of the CB2 for Inflammation

Cannabidiol as Emergent Therapeutic Strategy – Free Rad Biol Med_2012

Whole Plant Extracts Improve Neurogenic Symptoms – Clinical Rehab

Modulating the Endocannabinoid system in Human Health – FEBS_2013

A Molecular Link Between Marijuana and Alzheimer’s Disease Pathology

Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation

CBD Neuroprotection in pigs Neuropharmacology_2013

CBD prevents cerebral infarction in mice_Stroke_2005

Transdermal-delivery-of-cannabidiol-attenuates-alcohol-induced-neurodegeneration_2013

Neuroprotection by Delta9 THC

Cannabinoids New Promising Agents in the Treatment of Neurological Diseases

Cannabidiol and other cannabinoids reduce microglial activation in relevance to Alzheimer’s disease

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex

PTSD:

Endocannabinoid System as a target to treat PTSD

CBD, Non-psychoactive Cannabis Sativa constituent, as anxiolytic drug

Epilepsy:

CBD Displays Anti Epileptiform and Antiseizure Properties In Vitro and In Vivo

Cannabidivarin (CBDV) suppresses PTZ-induced increases in epilepsy-relate gene expression

Cannabidivarin (CBDV) is Anticonvulsant in Mouse and Rat

Multiple sclerosis:

Whole plant cannabis extracts for treatment of spasticity in MS

Cannabinoid Modulation of Neuroinflammatory Disorders

CBD inhibits pathogenic T cell, decreases spinal microglial multiple sclerosis

Symptomatic therapy in multiple sclerosis – The of cannabinoids

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

therapeutic effects experimental autoimmune encephalomyelitis

Cancer:

Cannabidiol Induces Programmed Cell Death in Breast Cancer

Cannabidiol as Anti-cancer Drug

Cannabidiol Inhibits Lung Cancer Cell Invasion and Metastasis

CBD Inhibits Angiogenesis by Multiple Mechanisms

Cannabis Extract Treatment for Terminal Acute Leukemia

CBD Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma

Tumor Apoptosis in Colon Cancer

Antitumor Effects of Cannabidiol on Human Glioma Cell Lines

Glioblastoma Multiforme

Combined Therapy of Cannabinoids and Temozolomide against Glioma

Cannabidiol Antitumor activity on Breast Cancer

Cannabinoids Reduce Breast Cancer Progression

Cannabidiol reduces breast cancer cell proliferation, invasion, metastasis

Endocannabinoid anandamide inhibits breast cancer cell proliferation

THC inhibits epithelial growth factor induced lung cancer cell migration

Cannabidiol CBD inhibits lung cancer cell invasion metastasis

Cannabinoid Receptors inhibit non-small cell lung cancer growth and metastasis

Non-THC cannabinoids inhibit prostate carcinoma growth

Cannabinoid receptor-mediated apoptosis in Mantle Cell Lymphoma

CB1 and CB2 receptor activation inhibits Non-Hodgkin Lymphoma growth

THC induces apoptosis in Jurkat Leukemia

Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells

Anti-tumoral action of cannabinoids on hepatocellular carcinoma

Cannabis and Cancer

Diabetes:

Impact of marijuana on diabetes in adults

HIV/AIDS and Anti-virals:

Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus

Osteoporosis and bone disorders:

Endocannabinoids regulate bone metabolism

Cannabinoid Receptors as Target for Treatment of Osteoporosis

CB2 Regulates Bone Mass

Antibacterial (Kills infectious disease like MRSA):

Antibacterial Cannabinoids from Cannabis Sativa

CB1 receptor antagonist inhibits macrophage infection

Fibromyalgia:

Cannabis treatment in fibromyalgia patients

Crohn’s Disease:

Cannabis Induces Clinical Response in Crohn’s Disease

Cannabinoids Alleviate Intestinal Inflammation

Studies Citing Cannabis’ Overall Medicinal Benefits:

Therapeutic aspects of cannabis and cannabinoids

Cannabidiol in Humans as Therapeutic Targets

Cannabinoids in Health and Disease

Cannabis and endocannabinoid modulators – Therapeutic promises and challenges

Cannabis synergy and phytocannabinoid-terpenoid entourage effects

Miscellaneous conditions (pain, liver, kidney, vascular, inflammation):

Endocannabinoid System and Pain

Cannabidiol Protects Against Hepatic Ischemia

Cannabidiol vs Aspirin and Tramadol

Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol

Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration

Human Endocannabinoid System (ECS)

Clinical Endocannabinoid Deficiency Syndrome

Endocannabinoid Anxiety and Depression

Phytocannabinoids and CB1 and CB2 receptors

You may notice that many of these studies were conducted in other countries like Israel, Germany and Canada.  This is due to marijuana’s Schedule 1 drug status.  This prohibits American scientists and universities from legally studying cannabis.
Imagine how much more we would learn if the best doctors and scientists in the world were allowed to research cannabis?